Back to Search Start Over

Unity Makes Strength: Exploring Intraspecies and Interspecies Toxin Synergism between Phospholipases A 2 and Cytotoxins.

Authors :
Pucca MB
Ahmadi S
Cerni FA
Ledsgaard L
Sørensen CV
McGeoghan FTS
Stewart T
Schoof E
Lomonte B
Auf dem Keller U
Arantes EC
Çalışkan F
Laustsen AH
Source :
Frontiers in pharmacology [Front Pharmacol] 2020 May 07; Vol. 11, pp. 611. Date of Electronic Publication: 2020 May 07 (Print Publication: 2020).
Publication Year :
2020

Abstract

Toxin synergism is a complex biochemical phenomenon, where different animal venom proteins interact either directly or indirectly to potentiate toxicity to a level that is above the sum of the toxicities of the individual toxins. This provides the animals possessing venoms with synergistically enhanced toxicity with a metabolic advantage, since less venom is needed to inflict potent toxic effects in prey and predators. Among the toxins that are known for interacting synergistically are cytotoxins from snake venoms, phospholipases A <subscript>2</subscript> from snake and bee venoms, and melittin from bee venom. These toxins may derive a synergistically enhanced toxicity via formation of toxin complexes by hetero-oligomerization. Using a human keratinocyte assay mimicking human epidermis in vitro , we demonstrate and quantify the level of synergistically enhanced toxicity for 12 cytotoxin/melittin-PLA <subscript>2</subscript> combinations using toxins from elapids, vipers, and bees. Moreover, by utilizing an interaction-based assay and by including a wealth of information obtained via a thorough literature review, we speculate and propose a mechanistic model for how toxin synergism in relation to cytotoxicity may be mediated by cytotoxin/melittin and PLA <subscript>2</subscript> complex formation.<br /> (Copyright © 2020 Pucca, Ahmadi, Cerni, Ledsgaard, Sørensen, McGeoghan, Stewart, Schoof, Lomonte, auf dem Keller, Arantes, Çalışkan and Laustsen.)

Details

Language :
English
ISSN :
1663-9812
Volume :
11
Database :
MEDLINE
Journal :
Frontiers in pharmacology
Publication Type :
Academic Journal
Accession number :
32457615
Full Text :
https://doi.org/10.3389/fphar.2020.00611